Overview

Dexmedetomidine and Remifentanil in NORA

Status:
COMPLETED
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) procedure is frequently encountered in non-operating room anesthesia applications (NORA). It is a procedure that requires deep sedation and analgesia in terms of gastroenterologist and patient comfort. Dexmedetomidine, which is increasingly used in NORA applications, comes to the fore because it does not cause respiratory depression, reduces the stress response, and provides hemodynamic stability. This study aims to compare the effects of dexmedetomidine-propofol (DP) and remifentanil-propofol (RP) combinations on hemodynamic stability, rapid recovery, and patient comfort in patients who underwent ERCP.
Phase:
PHASE4
Details
Lead Sponsor:
Baskent University Ankara Hospital
Treatments:
Dexmedetomidine
Remifentanil